Evidence map›Paper›PMID 34066104›Full record

ArticleCancers2021

Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results.

Ho Jung An, Eunkyung An, Shahrooz Rabizadeh, Wei-Li Liao, Jon Burrows, Todd Hembrough, Jin Hyung Kang, Chan Kwon Park, Tae-Jung Kim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ho Jung AnDepartment of Medical Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Eunkyung AnNantOmics, Culver City, CA 90232, USA.
Shahrooz RabizadehNantOmics, Culver City, CA 90232, USA.
Wei-Li LiaoNantOmics, Culver City, CA 90232, USA.
Jon BurrowsOncoPlex Diagnostics, Rockville, MD 20850, USA.
Todd HembroughOncoPlex Diagnostics, Rockville, MD 20850, USA.
Jin Hyung KangDepartment of Medical Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Chan Kwon ParkDivision of Pulmonology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Tae-Jung KimDepartment of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0003-3140-3681
OncoPlex Diagnostics (United States) · USThe Catholic University of Korea Yeouido St. Mary's Hospital · KRThe Catholic University of Korea Seoul St. Mary's Hospital · KRThe Catholic University of Korea St. Vincent's Hospital · KR

Funding

Nation Research Foundation of Korea through a grant funded by the Korean government (MSIT) 2017R1E1A1A01078335
6 · The paper itself

Abstract

Therapeutic guidance in non-small cell lung cancer (NSCLC) tumors that are positive for anaplastic lymphoma kinase (

Indexed as

ALKchemotherapyfluorescent in situ hybridizationimmunohistochemistrynon-small-cell lung cancerproteomicsselected reaction monitoringtyrosine kinase inhibitor

Identifiers

PMID34066104
PMCPMC8150487
OpenAlexW3160973006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.